Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Anticancer Research|May 16, 2009
Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I studyAndrea Mambrini, Paola Pacetti, Alfonso Del Freo, et al.
Tumori|October 1, 2008
Complete response of colorectal liver metastases after intra-arterial chemotherapyGiammaria Fiorentini, Alessandro Del Conte, Michele De Simone, et al.
Cancer|February 24, 2005
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumorsMaurizio Cantore, Andrea Mambrini, Giammaria Fiorentini, et al.
In Vivo (Athens, Greece)|May 21, 2009
Thoracic stop-flow perfusion for refractory lymphoma: a phase I-II evaluation trialCristina Ruscitti, Stefano Guadagni, Filippo Russo, et al.
In Vivo (Athens, Greece)|January 6, 2007
Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experienceAndrea Mambrini, Franco Sanguinetti, Paola Pacetti, et al.
Anticancer Research|May 16, 2009
Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabinePaola Pacetti, Elisa Giovannetti, Andrea Mambrini, et al.
Anticancer Research|April 12, 2012
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III studyGiammaria Fiorentini, Camillo Aliberti, Massimo Tilli, et al.
Anticancer Research|August 19, 2007
Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II studyAndrea Mambrini, Alfredo Guglielmi, Paola Pacetti, et al.
In Vivo (Athens, Greece)|May 6, 2009
Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical optionGiammaria Fiorentini, Marco Filippeschi, Gina Turrisi, et al.
American Journal of Clinical Oncology|December 15, 2004
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II studyVittorio D Ferrari, Vito Amoroso, Francesca Valcamonico, et al.
Pageof 9